Meet The Professors: Lung Cancer Edition, 2018 (Video Program)


MTPLung18

Discussion

 

Track 1: Case: A 72-year-old woman and heavy smoker with newly diagnosed metastatic adenosquamous non-small cell lung cancer (NSCLC) and a high PD-L1 tumor proportion score (TPS) (Dr Rodriguez)
Track 2: Choosing between pembrolizumab alone or in combination with carboplatin/pemetrexed as first-line therapy for nonsquamous metastatic NSCLC
Track 3: Clinical experience with immune checkpoint inhibitor-associated gastrointestinal toxicities
Track 4: Management of oligometastatic disease
Track 5: Case: A 63-year-old woman and current smoker with previously treated locally advanced adenocarcinoma of the lung now with brain metastases (Dr Ma)
Track 6: Chemo/radiation therapy options for locally advanced adenocarcinoma of the lung
Track 7: Identification, incidence and management of checkpoint inhibitor-associated immune-related side effects
Track 8: Case: An 88-year-old woman and current smoker presents with localized squamous cell carcinoma (SCC) of the lung and opts to forego active cancer treatment (Dr Martins)
Track 9: Potential link between diet, lifestyle and reduction of cancer risk
Track 10: Case: A 58-year-old woman and never smoker with locally advanced adenocarcinoma of the lung receives chemoradiation therapy followed by durvalumab on the Phase III PACIFIC trial (Dr Rodriguez)
Track 11: PACIFIC: Results of a Phase III trial of durvalumab after chemoradiation therapy for patients with Stage III locally advanced unresectable NSCLC
Track 12: First-line therapy options for metastatic nonsquamous NSCLC
Track 13: First-line therapy for metastatic SCC of the lung
Track 14: Choice of pemetrexed or paclitaxel in combination with carboplatin/bevacizumab for metastatic nonsquamous NSCLC
Track 15: Maintenance therapy options for metastatic nonsquamous NSCLC
Track 16: Community oncologist panel’s approach to first-line therapy for metastatic SCC of the lung
Track 17: Perspective on the clinical utility of necitumumab for metastatic SCC of the lung
Track 18: Activity and tolerability of ramucirumab/docetaxel as second-line therapy for advanced NSCLC
Track 19: Activity of immune checkpoint inhibitors in patients with NSCLC and brain metastases
Track 20: Molecular testing in patients with Stage IV NSCLC
Track 21: Biomarker-driven algorithm for sequencing of systemic therapy for metastatic NSCLC
Track 22: Duration of response to immune checkpoint inhibitors
Track 23: Case: A 45-year-old woman presents with Stage IV metastatic adenocarcinoma of the lung with no targetable mutations and receives nanoparticle albumin-bound (nab) paclitaxel/carboplatin (Dr Ma)
Track 24: Pemetrexed maintenance for Stage IV metastatic adenocarcinoma of the lung with no targetable mutations
Track 25: Detection of peritoneal metastases from adenocarcinoma of the lung
Track 26: Response and tolerability of ramucirumab/docetaxel in metastatic adenocarcinoma of the lung
Track 27: Immune checkpoint inhibitors in patients with paraneoplastic syndromes
Track 28: Contraindications to the use of ramucirumab
Track 29: Case: An 82-year-old woman with metastatic NSCLC receives second-line nivolumab (Dr Martins)
Track 30: Management of checkpoint inhibitor-related dermatologic toxicities
Track 31: Case: A 55-year-old woman and never smoker with adenocarcinoma of the lung and pleural metastases (Dr Rodriguez)
Track 32: Response and tolerability of cabozantinib in RET-rearranged adenocarcinoma of the lung
Track 33: Importance of setting physician-patient boundaries
Track 34: Satisfaction in providing end-of-life care for patients with lung cancer
 
FACULTY
 
Ramaswamy Govindan, MD
Professor of Medicine
Director, Section of Oncology
Anheuser-Busch
Endowed Chair in Medical Oncology
Washington University
School of Medicine
St Louis, Missouri
 
Corey J Langer, MD
Director of Thoracic Oncology
Abramson Cancer Center
Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Vice Chair
Radiation Therapy Oncology Group
Philadelphia, Pennsylvania
 
COMMUNITY ONCOLOGISTS
 
Yanjun Ma, MD, PhD
Medical Oncology
Tennessee Oncology
Nashville, Tennessee
 
Joseph Martins, MD
Tyler Hematology-Oncology
ETMC Lung Cancer
Tumor Board Moderator
Tyler, Texas
 
Estelamari Rodriguez, MD, MPH
Medical Director
Thoracic Oncology Chair
Women's Centered Care Network
Mount Sinai Medical Center
Comprehensive Cancer Center
Miami Beach, Florida
 
MODERATOR
 
Neil Love, MD
Research To Practice
Miami, Florida